PHOENIX, March 25, 2024 (GLOBE NEWSWIRE) — Mobivity Holdings Corp. (OTCQB: MFON), a provider of technology connecting mobile gaming audiences to real-world brands and products, today announced that the Company will release results for the… Read More »Mobivity Schedules Fourth Quarter and Year End 2023 Conference Call for Monday, April 1, 2024
EATONTOWN, N.J., March 25, 2024 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) was recently honored with the NAM Distributor of… Read More »Climb Channel Solutions Awarded NAM Distributor of the Year by Delinea
n2y, a trailblazer in special education curriculum resources, and Texthelp, the global leader in literacy and assistive technology have agreed to merge The combined business will globally serve learners with diverse needs as well… Read More »TEXTHELP AND N2Y JOIN FORCES TO MAKE EDUCATION AND THE WORKPLACE MORE INCLUSIVE FOR EVERYONE
GenieMD offers a comprehensive virtual care platform, integrating telehealth, remote patient monitoring, chronic care management, and AI-driven insights to impact the treatment and management of chronic diseases. SAN ANTONIO, March 25, 2024 /PRNewswire/ —… Read More »GenieMD Awarded Frost & Sullivan’s 2024 Company of the Year Award for Pioneering Virtual Chronic Disease Management Solutions Through Its Unified Virtual Care Platform
Imgesu Cetin, Founder and CEO, Genie AI, discussed data and query challenges with AI and how Genie AI is providing enterprise solutions with host, Enzo Villani, CEO, Alpha Transform Holdings Los Angeles, CA, March 25,… Read More »Imgesu Cetin, CEO, Genie AI, an NVIDIA Inception Program Company, Featured on the Blockchangers Podcast
Expanded Channel Program Enables Partners to Deliver New Products to Secure Their Customers CAMBRIDGE, Mass., March 25, 2024 (GLOBE NEWSWIRE) — ReversingLabs (RL), the trusted authority in software and file security, has been recognized by… Read More »ReversingLabs Earns Premier 5-Star Rating in 2024 CRN® Partner Program Guide